K. Ott

The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer

A. Eisen, S. Narod, K. Metcalfe, 2020, Breast Cancer Research and Treatment.

A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings

Y. Bombard, A. Eisen, S. Armel, 2022, Human Genetics.

Development of patient “profiles” to tailor counseling for incidental genomic sequencing results

Y. Bombard, A. Eisen, R. Kim, 2019, European Journal of Human Genetics.

Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?

T. Stockley, R. Kim, K. Metcalfe, 2022, Hereditary cancer in clinical practice.

Abstract P6-10-17: Rates of prophylactic surgeries among BRCA 1 or 2 mutation carriers: A single institution experience

A. Eisen, T. Mancuso, K. Ott, 2016 .

Development of patient “profiles” to tailor counseling for incidental genomic sequencing results

Y. Bombard, A. Eisen, R. Kim, 2019, European Journal of Human Genetics.

Patient‐reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high‐grade serous ovarian cancer

T. Stockley, R. Kim, K. Metcalfe, 2022, Journal of genetic counseling.

Quality of life drives patients’ preferences for secondary findings from genomic sequencing

S. Scherer, A. Laupacis, C. Earle, 2020, European Journal of Human Genetics.